
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🔥 13 hours ago
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
• Serve as a field-based scientific expert supporting engagement with healthcare professionals, investigators, treatment centers, and KOLs focused on autoimmune diseases and cell therapy • Identify, establish, and maintain scientific relationships with KOLs, investigators, academic medical centers, physicians, pharmacists, nurses, and treatment centers • Provide fair-balanced, accurate, and compliant scientific exchange on disease states, treatment landscapes, Kyverna’s CAR-T programs, and emerging clinical data • Act as a scientific liaison to investigators interested in clinical research collaborations and investigator-initiated research discussions • Develop and execute geography-specific Medical Affairs and KOL engagement plans • Own the assigned territory through stakeholder mapping, prioritization, and proactive planning • Partner with field medical colleagues to coordinate external engagement approaches • Support Kyverna-sponsored clinical trials through trial-site identification, investigator engagement, trial awareness, and scientific dialogue • Contribute to trial feasibility and enrollment efforts • Capture and communicate medical insights on autoimmune disease and cell therapy landscapes • Translate external scientific perspectives into actionable insights for medical, clinical, and development decisions • Collaborate with Clinical Development, Clinical Operations, Regulatory Affairs, Commercial, Market Access, and Patient Services teams within non-promotional boundaries • Provide scientific support at congresses, advisory boards, investigator meetings, and medical education forums • Respond compliantly to unsolicited medical information requests • Maintain current knowledge of therapeutic areas, treatment guidelines, clinical research processes, cell therapy operations, and treatment center workflows • Complete CRM documentation, administrative tasks, required training, and pharmacovigilance responsibilities, including adverse event and product complaint reporting • Conduct activities in compliance with applicable laws, regulations, and company policies
• Advanced scientific or clinical degree required (MD, PharmD, PhD, DNP, NP, PA, or equivalent) • MSL: Doctorate degree OR Master’s degree and 3 years of Medical Affairs experience • Senior MSL: Doctorate degree and 2 years of Medical Affairs experience OR Master’s degree and 6 years of Medical Affairs experience • Prior experience in cell therapy, CAR-T, immunology, rheumatology, nephrology, neurology, hematology/oncology, or rare diseases strongly preferred • Strong understanding of clinical trial design, clinical development, and medical affairs functions • Experience engaging with academic medical centers, specialty treatment centers, and/or infusion centers preferred • Ability to interpret and communicate complex scientific and clinical information to diverse audiences • Excellent presentation, communication, and interpersonal skills • Demonstrated ability to build strong external relationships and collaborate effectively across cross-functional teams • Comfortable operating within a fast-paced, high-growth biotechnology environment • Willingness and ability to travel extensively within assigned geography • Experience supporting pre-commercial or launch-stage biotechnology organizations • Knowledge of autoimmune disease treatment landscapes and emerging cell therapy approaches • Experience supporting investigator-sponsored research and clinical trial recruitment initiatives • Familiarity with cell therapy operational concepts including chain of identity, chain of custody, and treatment center workflows
• Bonus eligibility • Participation in the Company’s stock plan
Apply Now🔥 14 hours ago
Medical Science Liaison advancing Bristol Myers Squibb neuropsychiatry medicines across Georgia and Alabama. Building scientific partnerships, supporting research, and improving patient access.
🇺🇸 United States – Remote
💵 $166.1k - $201.3k / year
⏰ Full Time
🟡 Mid-level
🟠 Senior
🦅 H1B Visa Sponsor
🕒 Yesterday
Medical Science Liaison educating North Texas healthcare providers on Tempus AI-powered oncology assays and genomic testing. Supporting commercial teams, KOL relationships, scientific presentations, conferences, and market intelligence.
🕒 Yesterday
Senior Medical Science Liaison supporting Summit Therapeutics’ oncology clinical programs. Building HCP relationships and advancing scientific strategy across the Southern United States.
🇺🇸 United States – Remote
💵 $200k - $235k / year
🔥 Funding within the last year
💰 $500M Post-IPO Equity - Summit Therapeutics on 2025-10
⏰ Full Time
🟠 Senior
🕒 Yesterday
Medical Science Liaison advancing Sobi’s rare-disease therapies through KOL engagement and scientific communications. Driving country medical activities across specified German territories.
🕒 2 days ago
Medical Science Liaison advancing Deciphera Pharmaceuticals’ investigational and marketed oncology therapies. Building KOL relationships, supporting studies, and translating clinical insights into medical strategy.